|
|
Regulation Digest
December 2, 2020
Vol. 9, No. 47
Editor: Bryce Chinault
|
|
GW Regulatory Studies Center
SBCA
SSRN
The Regulatory Review
Urban Institute
Washington Legal Fdn.
Yale Journal on Reg.
American Action Forum
AEI
Brookings Institution
Cato Institute
CAP
CPR
CEI
Federalist Society
Heritage Foundation
Inst. for Policy Integrity
Mercatus Center
NBER
Progressive Policy Inst.
Reason
R Street Institute
RFF
Various Sources
|
|
Editor's Note: We hope you had a Happy Thanksgiving! We are incredibly grateful for everyone who has supported our mission over the past decade. |
Agency Rulemaking Highlights |
COVID-19 Related Actions
|
Other Notable Actions
The Centers for Medicare & Medicaid Services issued an interim final rule that "will test whether more closely aligning payment for Medicare Part B drugs and biologicals with international prices and removing incentives to use higher-cost drugs can control unsustainable growth in Medicare Part B spending without adversely affecting quality of care for beneficiaries." Effective November 27.
The Dept. of Health & Human Services issued a policy statement meant to encourage rulemaking best practices. Effective November 27.
HHS also issued a request for information to find regulations that do not meet this standard. Comments due December 21.
The Federal Communications Commission issued a final rule "to retarget universal service funding for mobile broadband and voice in the high-cost program to support the deployment of 5G services." Effective December 28.
The Dept. of Transportation issued a notice of proposed rulemaking "to update and codify its internal order establishing the responsibilities and procedures for complying with the National Environmental Policy Act." Comments due December 23.
The Dept. of Justice issued a final rule that would allow for executions by lethal injection or “any other manner prescribed by the law of the state in which the sentence was imposed.” Effective December 24.
The Consumer Product Safety Commission will host a forum regarding artificial intelligence on March 2, 2021. Anyone interested in participating should register by January 15.
|
Congress & Regulatory Reform
Financial Markets & Housing
Energy & Environment
Health & Safety
-
HHS Seeks Feedback on Pandemic Regulatory Actions, Government Executive
-
Pfizer, BioNTech’s Covid-19 Vaccine Authorized in the U.K., Wall Street Journal
-
Moderna Asks Health Regulators to Authorize Its Covid-19 Vaccine, Wall Street Journal
-
FDA Authorizes Regeneron’s Covid-19 Antibody Cocktail Drug, Wall Street Journal
-
After Admitting Mistake, AstraZeneca Faces Difficult Questions About Its Vaccine, New York Times
-
A Final Try by Trump to Cut Drug Prices May Stumble in Court, New York Times
-
Next Administration Could Mean New Safety Regulations For Coal Mines, NPR
-
New Rule Would Allow U.S. to Use More Methods for Executions, New York Times
-
Transportation Department finalizes rule limiting service animals on flights to dogs, The Hill
-
Court upholds FDA regulation of e-cigarettes as tobacco products, Reuters
Business
-
Facebook, Google to Face New Antitrust Suits in U.S., Wall Street Journal
-
Europe Doubles Down on Data Protection to Ward Off Silicon Valley, Chinese Influence, Wall Street Journal
-
China Panel Calls for More Federal Trade Commission Authority in Approving Mergers Involving Foreign Money, Wall Street Journal
-
Gig Workers Could Be Paid Partially in Stock Under SEC Proposal, Wall Street Journal
-
Department of Labor Regulation for Retirement Plans Is Now in Limbo, Wall Street Journal
-
For Big Tech, Biden Brings a New Era, But No Ease in Scrutiny, Bay News 9
Technology
|
|
If you found this information helpful, please consider a donation to the GW Regulatory Studies Center, and forward this email to your colleagues and friends.
|
|
|
|
|
|
|
